Altered plasma levels of zinc, copper, and iron during pregnancy are known to have profound effects on pregnant women and their neonates. The status of these elements is not known in pregnant women in Jordan. During the three trimesters of pregnancy, blood specimens were collected from 186 healthy pregnant women aged 17À45 years and from cord blood of 92 of their neonates. The mean neonatal birth weight was 3.34 ± 0.44 kg. Maternal and cord blood serum levels of zinc, copper, and iron were determined by atomic absorption spectrophotometry, and hemoglobin concentration was determined by hematology cell counter. The results indicate significantly lower serum zinc levels and higher copper and iron levels in cord blood than in maternal blood. During the three trimesters of pregnancy, the serum levels of zinc and copper significantly decreased and increased, respectively, whereas the levels of serum iron were unchanged. Significant positive correlation was observed only between zinc levels of cord blood and birth weight. During third trimester, the mean serum levels of zinc and iron were significantly lower in anemic pregnant women (group I: Hb less than 11.0 g/ dL, n = 36) than that in nonanemic pregnant women (group II: Hb > or = 11.0 g/dL, n = 56). There was no noticeable difference between group I and group II regarding cord blood parameters on one hand and neonatal birth weight on the other hand. Similar significant positive correlation was observed between serum zinc levels of cord blood and birth weight in both groups. These results indicate that Jordanian women during pregnancy follow a well-balanced and adequate diet regime.

BackgroundCord blood transplant is an accepted treatment for many malignant and non-malignant diseases. We sought to determine the feasibility of collecting cord blood in Jordan and the effect of maternal and fetal factors on the quality of the cord blood units.MethodsA total of 124 cord blood units were collected, and 75 (60%) cord blood units were included in this analysis. Cord blood volume, total nucleated cell (TNC) count, cell viability and CD34+ content were measured, and clonogenic assay was performed.ResultsThe mean volume of the collected units was 68.9 ml (range 40–115) with mean nucleated cell count of 6.5 x 108 (range 1–23.0). Our results showed a positive correlation between the volume of cord blood and TNC count (p=0.008), cell viability (p=0.001), CD34+ content (p=0.034) and the length of the umbilical cord (p=0.011). In addition, our results showed an inverse relation between the Colony Forming Unit-Granulocyte Macrophage (CFU-GM) concentration and the gestation duration (p=0.038).ConclusionWe conclude that it is feasible to collect cord blood units in Jordan with excellent TNC and CD34+ cell content. The volume of cord blood collected was associated with higher TNC count and CD34+ count. Efforts toward establishing public cord blood banks in our area are warranted.

Background: Cancer metastasis depends on cell motility which is driven by cycles of actin polymerization and depolymerization. Reactive oxygen species (ROS) and metabolic oxidative stress have long been associated with cancer. ROS play a vital role in regulating actin dynamics that are sensitive to oxidative modification. The current work aimed at studying the effects of sub-lethal metabolic oxidative stress on actin cytoskeleton, focal adhesion and cell migration. Materials and Methods: T47D human breast cancer cells were treated with 2-deoxy-D-glucose (2DG), L-buthionine sulfoximine (BSO), or doxorubicin (DOX), individually or in combination, and changes in intracellular total glutathione and malondialdehyde (MDA) levels were measured. The expression of three major antioxidant enzymes was studied by immunoblotting, and cells were stained with fluorescentphalloidin to evaluate changes in F-actin organization. In addition, cell adhesion and degradation ability were measured. Cell migration was studied using wound healing and transwell migration assays. Results: Our results show that treating T47D human breast cancer cells with drug combinations (2DG/BSO, 2DG/DOX, or BSO/DOX) decreased intracellular total glutathione and increased oxidized glutathione, lipid peroxidation, and cytotoxicity. In addition, the drug combinations caused a reduction in cell area and mitotic index, prophase arrest and a decreased ability to form invadopodia. The formation of F-actin aggregates was increased in treated T47D cells. Moreover, combination therapy reduced cell adhesion and the rate of cell migration. Conclusions: Our results suggest that exposure of T47D breast cancer cells to combination therapy reduces cell migration via effects on metabolic oxidative stress.

No abstract

No abstract